Ark Invest's Cathie Wood has been facing harsh criticism about her investing style, partially because she is an easy target as she elects to disclose portfolio moves on a daily basis, but also because she has arguably shown an unwillingness to admit analysis that misfired despite outsized declines in a majority of her top holdings over the last year.
She also continues to increase her exposure to some of her highest-conviction holdings, most recently in Teladoc Health Inc (NYSE:TDOC).
